Literature DB >> 21385220

Skin pain and skin discomfort is associated with quality of life in patients with psoriasis.

T M Ljosaa1, C Mork, A Stubhaug, T Moum, A K Wahl.   

Abstract

BACKGROUND: Patients with psoriasis commonly report severe sensory skin symptoms, sleep disturbance, psychological distress and impaired health related quality of life (HRQoL). However, the complex associations among these factors are poorly investigated in this patient group.
OBJECTIVES: The purpose of this study was to investigate the association between skin pain or skin discomfort and HRQoL, and explore whether sleep disturbance and psychological distress were mediators of these associations.
METHODS: A total of 139 psoriasis patients from a university hospital setting participated in this exploratory, cross-sectional study. Data were obtained through interviews and questionnaires (Dermatology Life Quality Index, General Sleep Disturbance Scale, Illness Perception Questionnaire) and analysed using a series of multiple regression analyses. HRQoL was the dependent variable. Independent variables and assumed mediators were entered into the model in a predefined order.
RESULTS: Skin pain, skin discomfort, sleep disturbance and psychological distress were significantly associated with HRQoL (all P < 0.05). Sleep disturbance was a partial mediator for the association between skin pain and HRQoL. No such mediation effect was found in terms of psychological distress. The total model explained 40% of the variance in HRQoL.
CONCLUSION: In this study, skin pain and skin discomfort were significantly related to HRQoL when controlling for demographic and clinical characteristics. In addition, sleep disturbance mediated the association between skin pain and HRQoL. An understanding of the complex association among physiological and psychological factors, and HRQoL is clinically important in order to provide proper treatment and care of patients with psoriasis.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 21385220     DOI: 10.1111/j.1468-3083.2011.04000.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  14 in total

Review 1.  Sleep Disorders and Psoriasis: An Update.

Authors:  Bruno Halioua; Clara Chelli; Laurent Misery; Jonathan Taieb; Charles Taieb
Journal:  Acta Derm Venereol       Date:  2022-04-27       Impact factor: 3.875

Review 2.  [The effect of treatment expectations on pruritus and skin pain].

Authors:  F Krefting; S Hölsken; M Schedlowski; W Sondermann
Journal:  Schmerz       Date:  2021-10-27       Impact factor: 1.629

3.  Exploring cannabis use and perspectives among psoriatic disease patients.

Authors:  Jackie Tsang; Orli Silverberg; Rohan Machhar; Remy Pollock; Daniel Pereira; Mitchell Sutton; Dafna D Gladman; Cheryl F Rosen
Journal:  Clin Rheumatol       Date:  2022-01-20       Impact factor: 3.650

Review 4.  Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review.

Authors:  Alasdair L Henry; Simon D Kyle; Sahil Bhandari; Anna Chisholm; Christopher E M Griffiths; Christine Bundy
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

5.  The experience of pain and redness in patients with moderate to severe plaque psoriasis.

Authors:  Mona L Martin; Kenneth Gordon; Lionel Pinto; Donald M Bushnell; Dina Chau; Hema N Viswanathan
Journal:  J Dermatolog Treat       Date:  2015-09-04       Impact factor: 3.359

6.  Prevalence and Severity of Dermatological Condition-Associated Skin Pain in the Chinese.

Authors:  Xiaohua Wang; Qingsong Lai; Baoqing Zheng; Li Ye; Si Wen; Yunling Yan; Bin Yang; Mao-Qiang Man
Journal:  J Pain Res       Date:  2020-05-26       Impact factor: 3.133

7.  Pain associated with psoriasis: systematic scoping review protocol.

Authors:  Ana Sanader Vucemilovic; Danijela Nujic; Livia Puljak
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

8.  The Impact of Skin Problems on the Quality of Life in Patients Treated with Anticancer Agents: A Cross-Sectional Study.

Authors:  Jaewon Lee; Jin Lim; Jong Seo Park; Miso Kim; Tae-Yong Kim; Tae Min Kim; Kyung-Hun Lee; Bhumsuk Keam; Sae-Won Han; Je-Ho Mun; Kwang Hyun Cho; Seong Jin Jo
Journal:  Cancer Res Treat       Date:  2017-12-14       Impact factor: 4.679

9.  Analyzing the value of an educational program for psoriasis patients: a prospective controlled pilot study.

Authors:  Corinna Bubak; Marthe-Lisa Schaarschmidt; Lisa Schöben; Wiebke Katharina Peitsch; Astrid Schmieder
Journal:  BMC Public Health       Date:  2019-11-19       Impact factor: 3.295

10.  Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris.

Authors:  George Kontochristopoulos; Anargyros Kouris; Athanasios Chantzaras; Athanasios Petridis; John Yfantopoulos
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.